إعلان
إعلان
WST
West Pharmaceutical Services, Inc.
278.50
USDبرعاية
-2.33
-0.83%
٠٧ يناير, ١٦:٠٠ UTC -5
مغلق
بعد الإغلاق
278.44
-0.07
-0.02%
تقارير أرباح WST
النسبة الإيجابية المفاجئة
WST تفوق 34 من 39 آخر التقديرات.
87%
التقرير التالي
بيانات التقرير القادم
١١ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$802.87M
/$1.85
التغير الضمني من Q3 25 (Revenue/ EPS)
-0.21%
/-5.61%
التغير الضمني من Q4 24 (Revenue/ EPS)
+7.22%
/+1.65%
West Pharmaceutical Services, Inc. earnings per share and revenue
On ٢٣ أكتوبر ٢٠٢٥, WST reported earnings of 1.96 USD per share (EPS) for Q3 25, beating the estimate of 1.69 USD, resulting in a 15.40% surprise. Revenue reached 804.60 مليون, compared to an expected 795.81 مليون, with a 1.10% difference. The market reacted with a +10.92% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 16 المحللين forecast an EPS of 1.85 USD, with revenue projected to reach 802.87 مليون USD, implying an نقصان of -5.61% EPS, and نقصان of -0.21% in Revenue from the last quarter.
الأسئلة الشائعة
What were West Pharmaceutical Services, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, West Pharmaceutical Services, Inc. reported EPS of $1.96, beating estimates by 15.4%, and revenue of $804.60M, 1.1% above expectations.
How did the market react to West Pharmaceutical Services, Inc.'s Q3 2025 earnings?
The stock price moved up 10.92%, changed from $277.00 before the earnings release to $307.25 the day after.
When is West Pharmaceutical Services, Inc. expected to report next?
The next earning report is scheduled for ١١ فبراير ٢٠٢٦.
What are the forecasts for West Pharmaceutical Services, Inc.'s next earnings report?
Based on 16
المحللين, West Pharmaceutical Services, Inc. is expected to report EPS of $1.85 and revenue of $802.87M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان